REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/01/2026
Back to search
Official data from USPTO
THERAPEUTIC MOMENTUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THERAPEUTIC MOMENTUM
ST13
US500000088592803Class
9
Filing
88592803
Registration
6373666
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/02/2026
Trademark type
Word
Nice classes
9
Filing date
08/26/2019
Registration date
06/01/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2021
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/15/2020
First use in commerce
07/30/2020
Drawing code
4
Owner type
16
Owner location
Livingston, NJ, US
Examiner
FALK, JONATHAN ROBERT
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
E. S. (pessoa física)
Representatives
Envision Science
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Audio books in the nature of biomedical research and novel therapeutics; Downloadable podcasts in the field of interviews
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/27/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/26/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/26/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/26/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/26/2021
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
04/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2020
GNRT
NON-FINAL ACTION E-MAILED
10/07/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/30/2020
GNRT
NON-FINAL ACTION E-MAILED
09/30/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/30/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/01/2020
IUAF
USE AMENDMENT FILED
08/18/2020
EISU
TEAS STATEMENT OF USE RECEIVED
08/18/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2020
PUBO
PUBLISHED FOR OPPOSITION
01/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/26/2019
GNRT
NON-FINAL ACTION E-MAILED
11/26/2019
CNRT
NON-FINAL ACTION WRITTEN
11/26/2019
DOCK
ASSIGNED TO EXAMINER
11/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2019
NWAP
NEW APPLICATION ENTERED
08/29/2019
Continuous trademark protection
Get notified about every new filing that threatens THERAPEUTIC MOMENTUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.